The Patent Finder
RS

Roche Sequencing Solutions, Inc.

First filing 2008
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Roche Nimblegen, Inc. (to 2017)

Previously recorded as Genia Technologies, Inc. (to 2020)

366 patents currently held

7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next US patent term in the Roche Sequencing Solutions, Inc. portfolio ends in Jun 2028, and more of its terms end in 2037 (69) than in any other year. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
23
Ending by 2030
Jun 2028
Next term end
157
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Methods of Identifying Multiple Epitopes in Cells US 10,144,950
The most cited patent in this portfolio, cited by 241 later US patents, top 1% of utility patents granted in 2018 in our data. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
Ends Aug 2032 · Medium confidence
Also notable
Systems and Methods for Characterizing a Molecule US 8,324,914
Cited by 160 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Sep 2030 · High confidence
Also notable
Systems and Methods for Forming a Nanopore in a Lipid Bilayer US 9,605,307
Cited by 74 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Ends Feb 2030 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 8 fees due Jan 4 to 30, 2027 · next Jan 4
  • 13 fees due Feb 6 to 28, 2027 · next Feb 6
  • 9 fees due Mar 1 to 26, 2027 · next Mar 1
  • 11 fees due Apr 1 to 30, 2027 · next Apr 1
  • 5 fees due May 5 to 21, 2027 · next May 5
  • 1 fee due Jun 19, 2027
    The maintenance fee for Two-Way Pump Selectable Valve and Bypass Waste Channel (US 11,846,281) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 7 fees due Jul 2 to 30, 2027 · next Jul 2
  • 4 fees due Aug 6 to 27, 2027 · next Aug 6
  • 12 fees due Sep 3 to 26, 2027 · next Sep 3
  • 7 fees due Oct 2 to 30, 2027 · next Oct 2
  • 7 fees due Nov 5 to 21, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 8 of the patents on this record were granted since Aug 24, 2026

What they patent

The largest of its 157 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,324,360High Throughput Nucleic Acid Sequencing by Expansion
In force
 · High confidence
In forceHigh confidence
US 8,349,565High Throughput Nucleic Acid Sequencing by Expansion
In force
 · High confidence
In forceHigh confidence
US 9,920,386High Throughput Nucleic Acid Sequencing by Expansion
In force
 · Medium confidence
In forceMedium confidence
US 10,900,068Methods and Systems for Solution Based Sequence Enrichment
In force
 · Low confidence
In forceLow confidence
US 7,939,259High Throughput Nucleic Acid Sequencing by Expansion
In force
 · High confidence
In forceHigh confidence
US 9,790,543Methods and Systems for Solution Based Sequence Enrichment
In force
 · Low confidence
In forceLow confidence
US 8,461,854Systems and Methods for Characterizing a Molecule
In force
 · High confidence
In forceHigh confidence
US 9,377,437Systems and Methods for Characterizing a Molecule
In force
 · High confidence
In forceHigh confidence
US 9,605,307Systems and Methods for Forming a Nanopore in a Lipid Bilayer
In force
 · High confidence
In forceHigh confidence
US 9,617,595Systems and Methods for Assembling a Lipid Bilayer on a Substantially Planar Solid Surface
In force
 · Medium confidence
In forceMedium confidence
10 of 366 patents shown.
Pro members see all 366.
Pro members: see all 366 patents
Also on record, not counted in the 366: 7 patents in force now held by others · 7 patents ended · 138 applications pending · 71 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited